Literature DB >> 17367070

Inhibition of angiogenesis induced by cerebral arteriovenous malformations using gamma knife irradiation.

Kaya Kiliç1, Deniz Konya, Ozlem Kurtkaya, Aydin Sav, M Necmettin Pamir, Türker Kiliç.   

Abstract

OBJECT: The authors studied the effect of Gamma Knife irradiation on angiogenesis induced by cerebral arteriovenous malformation (AVM) tissues implanted in the corneas of rats.
METHODS: Ten AVM specimens obtained from tissue resections performed at Marmara University between 1998 and 2004 were used. A uniform amount of tissue was implanted into the micropocket between the two epithelial layers of the cornea. Gamma Knife irradiation was applied with dose prescriptions of 15 or 30 Gy to one cornea at 100% isodose. Dosing was adjusted so that the implanted cornea of one eye received 1.5 Gy when 15 Gy was applied to the other cornea. Similarly, one cornea received 3 Gy when 30 Gy was applied to the other cornea. Angiogenic activity was graded daily by biomicroscopic observations. Forty-eight other rats were used for microvessel counting and vascularendothelial growth factor (VEGF) staining portions of the experiment. Micropieces of the specimens were again used for corneal implantation. Rats from each group were killed on Days 5, 10, 15, and 20, and four corneas from each group were examined. Gamma Knife irradiation dose dependently decreased AVM-induced neovascularization in the rat cornea as determined by biomicroscopic grading of angiogenesis, microvessel count, and VEGF expression.
CONCLUSIONS: The results suggest that Gamma Knife irradiation inhibits angiogenesis induced by AVM tissue in the cornea angiogenesis model. The data are not directly related to understanding how Gamma Knife irradiation occludes existing AVM vasculature, but to understanding why properly treated AVMs do not recur and do not show neovascularization after Gamma Knife irradiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367070     DOI: 10.3171/jns.2007.106.3.463

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis.

Authors:  Oksan Karal-Yilmaz; Abdulkadir Ozkan; Emel Akgun; Manolya Kukut; Kemal Baysal; Timucin Avsar; Turker Kilic
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

2.  Liquid embolization material reduces the delivered radiation dose: clinical myth or reality?

Authors:  F Bing; R Doucet; F Lacroix; J P Bahary; T Darsaut; D Roy; F Guilbert; J Raymond; A Weill
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

3.  Gamma knife radiosurgery for the treatment of glomus jugulare tumors.

Authors:  Ali Genç; Atilla Bicer; Ufuk Abacioglu; Selcuk Peker; M Necmettin Pamir; Turker Kilic
Journal:  J Neurooncol       Date:  2009-08-26       Impact factor: 4.130

4.  Angiographic characteristics of epileptogenic arteriovenous malformations and effectiveness in the seizure control after treatment with radiosurgery.

Authors:  Nicolas Cordero-Tous; Ana Maria Jorques-Infante; Lucia Santos-Martin; Pedro Pablo Alcazar-Romero; Eduardo Fandiño-Benito; Jose Maria Martin-Linares; Gonzalo Olivares-Granados; Angel Horcajadas-Almansa
Journal:  J Radiosurg SBRT       Date:  2014

5.  Temporal expression analysis of angiogenesis-related genes in brain development.

Authors:  Abdulkadir Ozkan; Atilla Biçer; Timuçin Avşar; Askin Seker; Zafer Orkun Toktaş; Süheyla Uyar Bozkurt; Ayse Nazli Başak; Türker Kılıç
Journal:  Vasc Cell       Date:  2012-10-01

Review 6.  Experimental Animal Models of Arteriovenous Malformation: A Review.

Authors:  Jude Amal Raj; Marcus Stoodley
Journal:  Vet Sci       Date:  2015-06-19

Review 7.  Hereditary Hemorrhagic Telangiectasia and Arterio-Venous Malformations-From Diagnosis to Therapeutic Challenges.

Authors:  Mariana Floria; Elena Diana Năfureanu; Diana-Elena Iov; Oana Sîrbu; Mihaela Dranga; Anca Ouatu; Daniela Maria Tănase; Oana Bogdana Bărboi; Vasile Liviu Drug; Mihail Dan Cobzeanu
Journal:  J Clin Med       Date:  2022-05-07       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.